Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (31-40 of 280) with videos related to

Pageof 28
Sort By:
Annals of Hematology|February 6, 2016
Oxaliplatin pharmacokinetics on hemodialysis in a patient with diffuse large B cell lymphomaMichael S Balzer, Hendrik Eggers, Michael Heuser, et al.
Der Internist|February 13, 2021
[Treatment-refractory anaemia in a 35-year-old heart transplant recipient on chronic hemodialysis]Christoph Schröder, Johannes Roeles, Adrian Schwarzer, et al.
British Journal of Haematology|May 30, 2026
A proposed refined definition of acute myeloid leukaemia patients ineligible for intensive therapy: The Integrated Comorbidity-ECOG-Age criteriaDaniel Weidl, Myrto Boukovala, Doris Glaser, et al.
Annals of Hematology|December 9, 2010
Genetic changes of miR-182 G106A: rather a polymorphism than a somatic mutationFrederik Damm, Birgit Markus, Felicitas Thol, et al.
Current Topics in Medicinal Chemistry|August 5, 2021
Rationalization of the activity Profile of Pyruvate Kinase Isozyme M2 (PKM2) Inhibitors using 3D QSARMerugumala Kusuma, Sahil Arora, Sourav Kalra, et al.
Journal of Medicinal Chemistry|November 2, 2021
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2Sahil Arora, Gaurav Joshi, Anuhar Chaturvedi, et al.
Annals of Hematology|April 17, 2020
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemiaCharu Gupta, Stefan Kaulfuss, Kerstin Görlich, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 13, 2015
Teleradiotherapy Network: Applications and Feasibility for Providing Cost-Effective Comprehensive Radiotherapy Care in Low- and Middle-Income Group Countries for Cancer PatientsNiloy Ranjan Datta, Michael Heuser, Massoud Samiei, et al.
Journal of Clinical Pharmacology|September 25, 2020
Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic MalignanciesAna Ruiz-Garcia, Naveed Shaik, Swan Lin, et al.
Haematologica|June 21, 2011
DNMT3A mutations are rare in childhood acute myeloid leukemiaFelicitas Thol, Michael Heuser, Frederik Damm, et al.
Pageof 28

Showing results (31-40 of 280) with videos related to

Sort By:
Pageof 28
Annals of Hematology|February 6, 2016
Oxaliplatin pharmacokinetics on hemodialysis in a patient with diffuse large B cell lymphomaMichael S Balzer, Hendrik Eggers, Michael Heuser, et al.
Der Internist|February 13, 2021
[Treatment-refractory anaemia in a 35-year-old heart transplant recipient on chronic hemodialysis]Christoph Schröder, Johannes Roeles, Adrian Schwarzer, et al.
British Journal of Haematology|May 30, 2026
A proposed refined definition of acute myeloid leukaemia patients ineligible for intensive therapy: The Integrated Comorbidity-ECOG-Age criteriaDaniel Weidl, Myrto Boukovala, Doris Glaser, et al.
Annals of Hematology|December 9, 2010
Genetic changes of miR-182 G106A: rather a polymorphism than a somatic mutationFrederik Damm, Birgit Markus, Felicitas Thol, et al.
Current Topics in Medicinal Chemistry|August 5, 2021
Rationalization of the activity Profile of Pyruvate Kinase Isozyme M2 (PKM2) Inhibitors using 3D QSARMerugumala Kusuma, Sahil Arora, Sourav Kalra, et al.
Journal of Medicinal Chemistry|November 2, 2021
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2Sahil Arora, Gaurav Joshi, Anuhar Chaturvedi, et al.
Annals of Hematology|April 17, 2020
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemiaCharu Gupta, Stefan Kaulfuss, Kerstin Görlich, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 13, 2015
Teleradiotherapy Network: Applications and Feasibility for Providing Cost-Effective Comprehensive Radiotherapy Care in Low- and Middle-Income Group Countries for Cancer PatientsNiloy Ranjan Datta, Michael Heuser, Massoud Samiei, et al.
Journal of Clinical Pharmacology|September 25, 2020
Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic MalignanciesAna Ruiz-Garcia, Naveed Shaik, Swan Lin, et al.
Haematologica|June 21, 2011
DNMT3A mutations are rare in childhood acute myeloid leukemiaFelicitas Thol, Michael Heuser, Frederik Damm, et al.
Pageof 28